Hence, it is possible that in a heterotypic tumor microenvironment, especially in glioma, FAT1 influences TGF-β expression in more than one cell type, thereby contributing to an immunosuppressive milieu. The gene discussed is TGFB1; the disease is central nervous system cancer.